全文获取类型
收费全文 | 33745篇 |
免费 | 3172篇 |
国内免费 | 23篇 |
出版年
2022年 | 280篇 |
2021年 | 589篇 |
2020年 | 316篇 |
2019年 | 441篇 |
2018年 | 512篇 |
2017年 | 422篇 |
2016年 | 708篇 |
2015年 | 1316篇 |
2014年 | 1342篇 |
2013年 | 1861篇 |
2012年 | 2287篇 |
2011年 | 2258篇 |
2010年 | 1428篇 |
2009年 | 1318篇 |
2008年 | 1863篇 |
2007年 | 1896篇 |
2006年 | 1721篇 |
2005年 | 1824篇 |
2004年 | 1736篇 |
2003年 | 1603篇 |
2002年 | 1608篇 |
2001年 | 325篇 |
2000年 | 250篇 |
1999年 | 373篇 |
1998年 | 439篇 |
1997年 | 286篇 |
1996年 | 267篇 |
1995年 | 243篇 |
1994年 | 236篇 |
1993年 | 255篇 |
1992年 | 249篇 |
1991年 | 227篇 |
1990年 | 212篇 |
1989年 | 231篇 |
1988年 | 227篇 |
1987年 | 214篇 |
1986年 | 208篇 |
1985年 | 224篇 |
1984年 | 262篇 |
1983年 | 237篇 |
1982年 | 306篇 |
1981年 | 318篇 |
1980年 | 284篇 |
1979年 | 229篇 |
1978年 | 240篇 |
1977年 | 211篇 |
1976年 | 188篇 |
1975年 | 174篇 |
1974年 | 190篇 |
1973年 | 157篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Based on its proven anabolic effects on bone in osteoporosis patients, recombinant parathyroid hormone (PTH1-34) has been evaluated as a potential therapy for skeletal repair. In animals, the effect of PTH1-34 has been investigated in various skeletal repair models such as fractures, allografting, spinal arthrodesis and distraction
osteogenesis. These studies have demonstrated that intermittent PTH1-34 treatment enhances and accelerates the skeletal repair process via a number of mechanisms, which include effects on mesenchymal
stem cells, angiogenesis, chondrogenesis, bone formation and resorption. Furthermore, PTH1-34 has been shown to enhance bone repair in challenged animal models of aging, inflammatory arthritis and glucocorticoid-induced
bone loss. This pre-clinical success has led to off-label clinical use and a number of case reports documenting PTH1-34 treatment of delayed-unions and non-unions have been published. Although a recently completed phase 2 clinical trial of PTH1-34 treatment of patients with radius fracture has failed to achieve its primary outcome, largely because of effective healing
in the placebo group, several secondary outcomes are statistically significant, highlighting important issues concerning the
appropriate patient population for PTH1-34 therapy in skeletal repair. Here, we review our current knowledge of the effects of PTH1-34 therapy for bone healing, enumerate several critical unresolved issues (e.g., appropriate dosing regimen and indications)
and discuss the long-term potential of this drug as an adjuvant for endogenous tissue engineering. 相似文献
2.
3.
HIF-1 expression in healing wounds: HIF-1alpha induction in primary inflammatory cells by TNF-alpha 总被引:12,自引:0,他引:12
4.
5.
6.
Maria V. Sergeeva Vadim V. Mozhaev Joseph O. Rich Yuri L. Khmelnitsky 《Biotechnology letters》2000,22(17):1419-1422
A novel biocatalytic reaction of transamidation of non-activated amides with amines is reported. Among 45 different lipolytic and proteolytic enzymes tested, only the lipase from Candida antarcticawas able to catalyze this reaction. The reaction proceeded with up to ca. 80% conversion in anhydrous methyl tert-butyl ether and worked with both N-substituted and unsubstituted amides. The biocatalytic transamidation is an equilibrium process and, therefore, higher conversions to the desired amide were achieved by using increased concentrations of the amine nucleophile. 相似文献
7.
Epithelial ovarian carcinoma (EOC), the major cause of gynaecological cancer death, is a heterogeneous disease classified into five subtypes. Each subtype has distinct clinical characteristics and is associated with different genetic risk factors and molecular events, but all are treated with surgery and platinum/taxane regimes. Tumour progression and chemoresistance is generally associated with major metabolic alterations, notably altered mitochondrial function(s). Here, we report for the first time that the expression of the mitochondrial regulators PGC1α and TFAM varies between EOC subtypes; furthermore, we have identified a profile in clear-cell carcinoma consisting of undetectability of PGC1α/TFAM, and low ERα/Ki-67. By contrast, high-grade serous carcinomas were characterised by a converse state of PGC1α/TFAM, ERα positivity and a high Ki-67 index. Interestingly, loss of PGC1α/TFAM and ERα was found also in a non-clear cell EOC cell line made highly resistant to platinum in vitro. Similar to clear-cell carcinomas, these resistant cells also showed accumulation of glycogen. Altogether, our data provide mechanistic insights into the chemoresistant nature of ovarian clear-cell carcinomas. Furthermore, these findings corroborate the need to take into account the diversity of EOC and to develop subtype specific treatment strategies. 相似文献
8.
9.
Edward Harrison 《BMJ (Clinical research ed.)》1916,1(2888):645-647
10.
Transcriptional regulatory network triggered by oxidative signals configures the early response mechanisms of japonica rice to chilling stress 总被引:3,自引:0,他引:3